Litcius/Paper detail

Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

Lauren Rogak, Jamie K. Forschmiedt, Ethan Basch, Gina L. Mazza, Minji K. Lee, Eric A. Meek, Brenda Ginos, Blake Langlais, Brie N. Noble, Allison M. Deal, Claire Yee, Gita Thanarajasingam, Amylou C. Dueck

2025Contemporary Clinical Trials Communications7 citationsDOIOpen Access PDF

Abstract

< .001). PRO-CTCAE has had substantial and growing use in oncology trials since its release.

Topics & Concepts

Common Terminology Criteria for Adverse EventsTerminologyAdverse effectClinical trialMedicineClinical OncologyOncologyMEDLINEInternal medicineIntensive care medicineMedical physicsCancerBiologyLinguisticsPhilosophyBiochemistryClinical practice guidelines implementationHealth Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer
Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials | Litcius